Fluid Responsiveness Evaluation by AbdomiNal Compression in Kids Based on the STARLING Concept
Launched by HOPITAL LOUIS PRADEL · Jul 21, 2015
Trial Information
Current as of June 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \< 8 years old
- * Patient with a circulatory failure defined as follow :
- • Treatment including vasopressor or inotrope
- • OR macrocirculatory failure
- • Heart rate \> 2 Standard Deviation (SD)
- • Systolic arterial pressure \< 2 SD
- • Mean arterial pressure \< 2 SD
- • Diastolic arterial pressure \< 2 SD
- • WITH signs of microcirculatory failure
- • Capillary refill time \> 2 secondes
- • Blotch
- • Organ dysfunction due to the circulatory failure (Oliguria \< 0,5 ml/kg/h, acute lung injury, encephalopathy)
- Exclusion Criteria:
- • Opposition from the parents or the one who holds the parental authority
- • Cardiogenic acute pulmonary edema,
- • Extreme hemodynamic instability,
- • Intra-abdominal hypertension,
- • Recent abdominal surgery that does not permit an abdominal compression without causing pain.
- • Patient with mechanical circulatory support, such as Extra Corporal Life Support or Berlin-Heart
- • Patient with congenital cardiopathy with a palliative correction or an incomplete correction
- • Open thorax
- • Prone position
- • Investigators not available
- • No security number registration.
- • Moribund patient
About Hopital Louis Pradel
Hospital Louis Pradel is a renowned healthcare institution specializing in cardiovascular and metabolic diseases, dedicated to advancing medical research and improving patient outcomes. With a strong commitment to innovation, the hospital actively conducts clinical trials aimed at evaluating new therapeutic interventions and medical technologies. Backed by a team of experienced researchers and healthcare professionals, Hospital Louis Pradel fosters a collaborative environment that prioritizes patient safety and ethical standards, ensuring that all trials contribute valuable insights to the medical community and enhance the quality of care provided to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
Lyon, , France
Patients applied
Trial Officials
Jean-Luc Fellahi, MD, PhD
Study Director
Hôpital Louis Pradel, Hospice Civil de Lyon
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials